tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SABS Stock Latest News

SAB Biotherapeutics: Favorable SAB-142 Safety Profile and De-Risked Phase 2b Design Underpin Buy Rating
RatingsSAB Biotherapeutics: Favorable SAB-142 Safety Profile and De-Risked Phase 2b Design Underpin Buy Rating
6d ago
SABS
SAB Biotherapeutics initiated with a Buy at Guggenheim
PremiumThe Fly
SAB Biotherapeutics initiated with a Buy at Guggenheim
6d ago
SABS
SAB Biotherapeutics announces first patient dosed in SAFEGUARD trial
PremiumThe Fly
SAB Biotherapeutics announces first patient dosed in SAFEGUARD trial
7d ago
SABS
SAB Biotherapeutics Phase 1 trial of SAB-142 met primary endpoint
PremiumThe Fly
SAB Biotherapeutics Phase 1 trial of SAB-142 met primary endpoint
8d ago
SABS
Eleven new option listings and two option delistings on December 8th
PremiumThe Fly
Eleven new option listings and two option delistings on December 8th
17d ago
UL
DOOO
SAB Biotherapeutics to present data on progress in development of SAB-142
PremiumThe FlySAB Biotherapeutics to present data on progress in development of SAB-142
17d ago
SABS
SAB Biotherapeutics Reports Positive Q3 2025 Earnings
Premium
Company Announcements
SAB Biotherapeutics Reports Positive Q3 2025 Earnings
1M ago
SABS
Sab Biotherapeutics, Inc. (SABS) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Sab Biotherapeutics, Inc. (SABS) Q3 Earnings Cheat Sheet
1M ago
SABS
Promising Clinical Developments and Strategic Decisions Justify Buy Rating for SAB Biotherapeutics
PremiumRatings
Promising Clinical Developments and Strategic Decisions Justify Buy Rating for SAB Biotherapeutics
1M ago
SABS
Promising Phase 1 Data for SAB-142 Supports Buy Rating for SAB Biotherapeutics
PremiumRatings
Promising Phase 1 Data for SAB-142 Supports Buy Rating for SAB Biotherapeutics
2M ago
SABS
Sab Biotherapeutics’ New Study Targets Type 1 Diabetes Progression
PremiumCompany Announcements
Sab Biotherapeutics’ New Study Targets Type 1 Diabetes Progression
2M ago
SABS
SAB Biotherapeutics Board Members Resign in Agreement
PremiumCompany Announcements
SAB Biotherapeutics Board Members Resign in Agreement
3M ago
8K
SABS
SAB Biotherapeutics Approves Equity Plan Amendments
PremiumCompany AnnouncementsSAB Biotherapeutics Approves Equity Plan Amendments
3M ago
8K
SABS
Promising Developments and Strategic Partnerships Drive Buy Rating for SAB Biotherapeutics’ SAB-142
Premium
Ratings
Promising Developments and Strategic Partnerships Drive Buy Rating for SAB Biotherapeutics’ SAB-142
3M ago
SABS
SAB Biotherapeutics highlights data in multiple presentations at EASD
Premium
The Fly
SAB Biotherapeutics highlights data in multiple presentations at EASD
3M ago
SABS
SAB Biotherapeutics initiated with an Outperform at Leerink
PremiumThe Fly
SAB Biotherapeutics initiated with an Outperform at Leerink
3M ago
SABS
SAB Biotherapeutics files to sell 250M shares of common stock for holders
PremiumThe Fly
SAB Biotherapeutics files to sell 250M shares of common stock for holders
4M ago
SABS
SAB Biotherapeutics price target lowered to $12 from $20 at Chardan
PremiumThe Fly
SAB Biotherapeutics price target lowered to $12 from $20 at Chardan
5M ago
SABS
SAB Biotherapeutics Reports Increased Losses Amid Funding Boost
PremiumCompany Announcements
SAB Biotherapeutics Reports Increased Losses Amid Funding Boost
5M ago
SABS
SAB Biotherapeutics Secures $175M Funding, Paving Way for Phase 2b Diabetes Trial and Justifying Buy Rating
PremiumRatingsSAB Biotherapeutics Secures $175M Funding, Paving Way for Phase 2b Diabetes Trial and Justifying Buy Rating
5M ago
SABS
SAB Biotherapeutics reports Q2 EPS ($1.09) vs. (79c) last year
Premium
The Fly
SAB Biotherapeutics reports Q2 EPS ($1.09) vs. (79c) last year
5M ago
SABS
SAB Biotherapeutics Secures $175M Investment, Strengthening Financial Position and Advancing Type 1 Diabetes Treatment
Premium
Ratings
SAB Biotherapeutics Secures $175M Investment, Strengthening Financial Position and Advancing Type 1 Diabetes Treatment
5M ago
SABS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >